US BANCORP \DE\ - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 147 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$2,890
-39.2%
1,7100.0%0.00%
Q2 2023$4,754
+113.6%
1,710
+39.8%
0.00%
Q1 2023$2,226
-61.4%
1,223
+7.7%
0.00%
Q4 2022$5,760
+188.0%
1,136
+250.6%
0.00%
Q3 2022$2,000
+100.0%
3240.0%0.00%
Q2 2022$1,000
-50.0%
3240.0%0.00%
Q1 2022$2,000
-50.0%
324
-44.7%
0.00%
Q4 2021$4,000
-84.0%
586
-77.3%
0.00%
Q3 2021$25,000
-56.1%
2,586
-35.1%
0.00%
Q2 2021$57,000
-40.0%
3,9840.0%0.00%
Q1 2021$95,0003,9840.00%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 335,709$933,2710.26%
ALLEN HOLDING INC /NY 687,571$1,911,4470.26%
Clearwater Capital Advisors, LLC 394,599$1,096,9860.13%
SHEETS SMITH WEALTH MANAGEMENT 269,129$748,1790.11%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$268,0840.10%
WEALTH EFFECTS LLC 71,000$197,3800.09%
Virtus ETF Advisers LLC 37,888$105,3290.06%
DARK FOREST CAPITAL MANAGEMENT LP 203,659$566,1720.05%
Bell & Brown Wealth Advisors, LLC 20,100$55,8780.03%
FISHMAN JAY A LTD/MI 162,000$450,3600.03%
View complete list of IMMUNITYBIO INC shareholders